Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial

BACKGROUND: The aim of the present open-label, randomized control trial was to determine the clinical efficacy and safety of two 1-week bismuth-containing quadruple regimens and 1 levofloxacin-based triple regimen for the eradication of Helicobacter pylori infection in treatment-naive patients. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Jing, Zhou, Xiaoying, Chen, Han, Hao, Bo, Zhang, Weifeng, Zhang, Guoxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319494/
https://www.ncbi.nlm.nih.gov/pubmed/28207505
http://dx.doi.org/10.1097/MD.0000000000005859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319494/
https://www.ncbi.nlm.nih.gov/pubmed/28207505
http://dx.doi.org/10.1097/MD.0000000000005859

Ejemplares similares